HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo.

“The UCI takes a bold and necessary stance by banning the repeated use of carbon-monoxide inhalation on medical grounds,” UCI ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

President Trump held a phone call today with Vladimir Putin that he described as “lengthy and highly productive.” He ...

Semaglutide has already shown its value in ... in osteoarthritis patients’ pain and physical function in the STEP 9 trial. New HHS Secretary RFK Fr has been given the task of investigating ...

Diabetes UK reported that more than 12 million people in the UK are now living with diabetes or prediabetes. The total ...

Q4 2024 Earnings Call Transcript February 12, 2025 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699 ...